Related Articles
Anti-tumor and cell cycle responses in KB cells treated with a chimeric anti-EGFR monoclonal antibody in combination with cisplatin
MONOCLONAL-ANTIBODIES TO HUIFN-ALPHA SPECIES APPLIED TO THE STUDY OF IFN-RECEPTOR INTERACTION INDICATE THAT RECEPTOR DOWN-REGULATION DOES NOT OCCUR IN DAUDI CELLS
EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.
INHIBITION OF EXPERIMENTAL METASTASIS OF HUMAN BREAST-CARCINOMA CELLS IN ATHYMIC NUDE-MICE BY ANTI-ALPHA(5)BETA(1) FIBRONECTIN RECEPTOR INTEGRIN ANTIBODIES
THE GROWTH-RESPONSE OF HUMAN TUMOR-CELL LINES EXPRESSING THE EGF RECEPTOR TO TREATMENT WITH EGF AND OR MABS THAT BLOCK LIGAND-BINDING